• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Oncology division

























He wasn't fired he left while he could. West Coast RBL is in more hot water than cressy. They need to bring back people that left because of their incompetence. But, they probably wouldn't come back
 




































Words out: asco, at lunch hour, the rbds texted Tory to ask him to join them at the lunch they had already sat down for. His response: no thank you I’m on the convention floor seeing YOUR customers. I wonder if that had something to do with south rbd exiting.
 




Words out: asco, at lunch hour, the rbds texted Tory to ask him to join them at the lunch they had already sat down for. His response: no thank you I’m on the convention floor seeing YOUR customers. I wonder if that had something to do with south rbd exiting.


Tory is a clueless jackass. Big pharma hack.
 




He is very well liked and way less big Pharma than the last couple of outside hires for this position. Too bad it didn’t happen years ago. The turnover rate wouldn’t be as high as it is.